Enanta Pharmaceuticals Inc (ENTA)

[willyw]

Hep B has proven to be a tough nut to crack.

I don't think this will be a drug that will be used on HBV.
I've seen a few investigations that were HCV related, and I think one HBV related; I didn't think that a cyclophilin inhibitor use could be so broad.....but I saw someone was attempting it.

At one of the stock pitches someone asked Jay Luly about it; He seemed almost unaware of a different cyclophilin drug in development, very non committal about it's use for HBV, but I got the impression that it wasn't in the cards for this specific compound.

I hope that Luly will take about the compound at the ENTA earnings meeting later this month.

I will remember to keep my eye out and let you know if I see something interesting/promising.